• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Beyond the codes: The power of clinical notes in Truveta Data

Beyond the codes: The power of clinical notes in Truveta Data

by Truveta staff | Jan 9, 2025 | Research

In the world of medical research, data drives discovery. But until recently, nearly 80% of data relevant to research has been hidden in clinical notes. These notes include detailed observations, symptoms, and treatment plans that are absent from the structured data...
Exploring mental health-related emergency department visits

Exploring mental health-related emergency department visits

by Truveta Research | Dec 21, 2024 | Research, Research Insights

In an exclusive analysis for the Wall Street Journal, Truveta Research explored mental health-related emergency department visits. The rate of ED encounters related to mental health conditions peaked in 2021 for all conditions studied, besides schizophrenia, which...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

by Truveta staff | Dec 19, 2024 | Research

Between the last week of October and the last week of November, there was a 58.8% increase in respiratory virus-associated hospitalizations. For infants and children under the age of 5, respiratory viruses are now associated with 7.9% of hospitalizations in this...
Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

by Truveta Research | Dec 16, 2024 | Research, Research Insights

In partnership with Reuters, Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea within 15 days of their first-time GLP-1 prescriptions. Truveta Research found that for...
Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

by Truveta Research | Dec 14, 2024 | Research, Research Insights

First-time amphetamine/dextroamphetamine prescription rates remained stable overall, but increased significantly for people 30-44, 45-64, and 65+ years of age. The percentage of prescriptions filled within 5 days of being written reached their lowest values in March...
Adderall shortage: Exploring first-time ADHD diagnosis rates

Adderall shortage: Exploring first-time ADHD diagnosis rates

by Truveta Research | Dec 11, 2024 | Research, Research Insights

The rate of first-time ADHD diagnoses has increased since 2021. The largest increases in first-time ADHD diagnosis rates were seen in the 30-44-year-old and 45-64-year-old age groups. Age groups under 30 years old did not see increases in first-time ADHD diagnosis...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world evidence on heart failure from GLP-1 and advanced CKD populations
  • Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
  • Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.